UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 30, 2024
Accession Number:
0001213900-24-036125
Submission Type:
POS AM
CIK:
0001173313
Company Name:
ABVC BIOPHARMA, INC.
File Number:
333-255112